• Press Release

CarepathRx Announces Home Infusion Partnership with Mount Sinai Health System

  • New York, NY
  • (April 27, 2022)

CarepathRx, a leader in health system pharmacy and medication management solutions, today announced a comprehensive home infusion pharmacy partnership with Mount Sinai Health System, New York City’s largest academic health system. This multi-year agreement will expand patient access to home infusion therapies across the Mount Sinai Health System, encompassing its eight hospitals and ambulatory footprint.

“Mount Sinai is a leader in advancing hospital-level care at home and this comprehensive home infusion program is another key step in the expansion of this innovative model. The partnership with CarepathRx will enhance Mount Sinai’s response to the health-related needs of the diverse populations we serve and is an excellent alternative for patients that require IV-related therapies,” said Susan Mashni, PharmD, Senior Vice President and Chief Pharmacy Officer at Mount Sinai Health System.

“The home infusion program improves care continuity and aligns with Mount Sinai’s goal to deliver high-quality, equitable, accessible, and affordable therapies through new models of care,” added Hollis Kessler, Pharmacy Chief Transformation Officer at Mount Sinai Health System.

“We are excited to partner with Mount Sinai to expand their capabilities to provide home infusion services to the patients they serve,” said Kathie Patrick, President of CarepathRx Specialty Pharmacy & Infusion Solutions. “Our home infusion program provides hospital-level care within the home environment – leveraging this setting to help reduce costs, support improved outcomes, and enhance the patient experience. We greatly look forward to working with Mount Sinai.”

“Ambulatory care is one of the fastest growing segments of healthcare and home infusion is the fastest growing segment of ambulatory care,” added David Adair, Vice President of Health System Pharmacy Solutions at CarepathRx Specialty Pharmacy & Infusion Solutions. “CarepathRx’s end-to-end home infusion program helps health systems like Mount Sinai move into this treatment space efficiently and in a timely fashion.”

About CarepathRx

CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.


About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.  

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.  

Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research. 

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.